Correlation Between Arcellx and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Arcellx and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Novo Nordisk AS, you can compare the effects of market volatilities on Arcellx and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Novo Nordisk.
Diversification Opportunities for Arcellx and Novo Nordisk
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Arcellx and Novo is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Arcellx i.e., Arcellx and Novo Nordisk go up and down completely randomly.
Pair Corralation between Arcellx and Novo Nordisk
Given the investment horizon of 90 days Arcellx is expected to generate 1.31 times more return on investment than Novo Nordisk. However, Arcellx is 1.31 times more volatile than Novo Nordisk AS. It trades about 0.08 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.02 per unit of risk. If you would invest 5,110 in Arcellx on August 24, 2024 and sell it today you would earn a total of 3,612 from holding Arcellx or generate 70.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcellx vs. Novo Nordisk AS
Performance |
| Timeline |
| Arcellx |
| Novo Nordisk AS |
Arcellx and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcellx and Novo Nordisk
The main advantage of trading using opposite Arcellx and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |